XML 30 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders' Equity
12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stockholders' Equity
STOCKHOLDERS’ EQUITY
Preferred Stock
We have authorized 500 million shares of $0.01 par value preferred stock. No preferred stock was outstanding for any period presented.
Common Stock
Common shares outstanding plus shares underlying outstanding stock awards totaled 490 million, 497 million, and 504 million, as of December 31, 2015, 2016, and 2017. These totals include all vested and unvested stock awards outstanding, including those awards we estimate will be forfeited.
Stock Repurchase Activity
In February 2016, the Board of Directors authorized a program to repurchase up to $5.0 billion of our common stock, with no fixed expiration. This stock repurchase authorization replaced the previous $2.0 billion stock repurchase authorization, approved by the Board of Directors in 2010. There were no repurchases of common stock in 2015, 2016, or 2017.
Stock Award Plans
Employees vest in restricted stock unit awards and stock options over the corresponding service term, generally between two and five years.
Stock Award Activity
Stock options outstanding, which were primarily obtained through acquisitions, totaled 0.2 million, 0.1 million, and 0.1 million, as of December 31, 2015, 2016, and 2017.
Stock-based compensation expense is as follows (in millions):
 
Year Ended December 31,
 
2015
 
2016
 
2017
Cost of sales (1)
$

 
$
16

 
$
47

Fulfillment
482

 
657

 
911

Marketing
190

 
323

 
511

Technology and content
1,224

 
1,664

 
2,305

General and administrative
223

 
315

 
441

Total stock-based compensation expense (2)
$
2,119

 
$
2,975

 
$
4,215


___________________
(1)
Beginning in 2016, stock-based compensation expense was recorded to cost of sales for eligible employees providing delivery services.
(2)
The related tax benefits were $593 million, $907 million, and $860 million for 2015, 2016, and 2017. In 2017, the tax benefit reflects the permanent reduction in the U.S. statutory corporate tax rate from 35% to 21%.
The following table summarizes our restricted stock unit activity (in millions):
 
Number of Units
 
Weighted Average
Grant-Date
Fair Value
Outstanding as of January 1, 2015
17.4

 
$
285

Units granted
9.8

 
426

Units vested
(5.6
)
 
253

Units forfeited
(2.7
)
 
321

Outstanding as of December 31, 2015
18.9

 
362

Units granted
9.3

 
660

Units vested
(6.1
)
 
321

Units forfeited
(2.3
)
 
440

Outstanding as of December 31, 2016
19.8

 
506

Units granted
8.9

 
946

Units vested
(6.8
)
 
400

Units forfeited
(1.8
)
 
649

Outstanding as of December 31, 2017
20.1

 
$
725


Scheduled vesting for outstanding restricted stock units as of December 31, 2017, is as follows (in millions):
 
Year Ended  
 
 
 
 
 
2018
 
2019
 
2020
 
2021
 
2022
 
Thereafter
 
Total
Scheduled vesting—restricted stock units
7.3

 
7.3

 
3.6

 
1.6

 
0.1

 
0.2

 
20.1


As of December 31, 2017, there was $6.4 billion of net unrecognized compensation cost related to unvested stock-based compensation arrangements. This compensation is recognized on an accelerated basis with approximately half of the compensation expected to be expensed in the next twelve months, and has a weighted-average recognition period of 1.1 years. The estimated forfeiture rate as of December 31, 2015, 2016, and 2017 was 28%. Changes in our estimates and assumptions relating to forfeitures may cause us to realize material changes in stock-based compensation expense in the future.
During 2015, 2016, and 2017, the fair value of restricted stock units that vested was $2.7 billion, $4.3 billion, and $6.8 billion.
As matching contributions under our 401(k) savings plan, we granted 0.1 million shares of common stock in 2016 and 2017. Shares granted as matching contributions under our 401(k) plan are included in outstanding common stock when issued, and recorded as stock-based compensation expense.
Common Stock Available for Future Issuance
As of December 31, 2017, common stock available for future issuance to employees is 116 million shares.